Skip to main content
Top
Published in: Infection 5/2023

07-04-2023 | Streptococci | Research

Microbiologic diagnostics and pathogen spectrum in infective endocarditis of surgically treated patients: a five-year, retrospective, monocentric study

Authors: Renate Ziegler, Hendrik Arnold, Ralph Bertram, Walter Geißdörfer, Matthias Pauschinger, Theodor Fischlein, Francesco Pollari, Joerg Steinmann

Published in: Infection | Issue 5/2023

Login to get access

Abstract

Purpose

The spectrum of causative organisms in infective endocarditis (IE) has changed significantly in the last decades. Reliable pathogen detection is crucial for appropriate antimicrobial therapy for IE. The aim of the study was to evaluate the diagnostic value of microbiological methods for detecting the causative microorganism of IE and to analyze the spectrum of pathogens.

Methods

A total of 224 cases (211 unique patients, some with multiple surgeries) were included into this retrospective study. Patients were diagnosed with IE according to the modified Duke criteria from January 2016 to July 2021 and underwent heart valve surgery in a tertiary hospital. Pathogen detection was performed by blood culture, microbiological culture and 16S rDNA PCR of explanted heart valve material.

Results

A causative pathogen of IE was detected in 95.5% (n = 214) of cases. Blood cultures were positive in 83.3%, while a pathogen in the examined heart valve samples was identified in 32.6% by culture and in 88.2% by 16S rDNA PCR. A microorganism was identified by 16S rDNA PCR in 61.1% of blood culture negative cases but only in 19.4% by heart valve culture. The most common pathogens were Staphylococcus aureus (27%), viridans group streptococci (20%), enterococci (19%) and coagulase-negative staphylococci (CoNS 8%). Cutibacterium acnes (7%) was detected in prosthetic valve IE cases only.

Conclusion

Blood culture as a comparatively non-invasive and straightforward technique remains an important and reliable method for initial detection of the causative organism in IE. Diagnostic stewardship programs should broadly emphasize proper collection of blood cultures, particularly sampling prior to any antibiotic treatment. Additionally, molecular testing using 16S rDNA tissue PCR can be used with culture techniques to increase the diagnostic yield, especially in the case of a negative blood culture.
Literature
1.
8.
go back to reference Salzberger B, Glück T. Endokarditis: Diagnostik, Therapie, Prophylaxe: Update 2019: Erregerspektrum, Diagnose, Therapie, Komplikationen, Prophylaxe. InfectoPharm; 2019. Salzberger B, Glück T. Endokarditis: Diagnostik, Therapie, Prophylaxe: Update 2019: Erregerspektrum, Diagnose, Therapie, Komplikationen, Prophylaxe. InfectoPharm; 2019.
11.
go back to reference Mauch H, Podbielski A, Herrmann M, Seifert H, Abele-Horn M, Fätkenheuer G, et al. Blutkulturdiagnostik. 2nd ed. Amsterdam: Elsevier; 2007. Mauch H, Podbielski A, Herrmann M, Seifert H, Abele-Horn M, Fätkenheuer G, et al. Blutkulturdiagnostik. 2nd ed. Amsterdam: Elsevier; 2007.
14.
go back to reference Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128. https://doi.org/10.1093/eurheartj/ehv319.CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128. https://​doi.​org/​10.​1093/​eurheartj/​ehv319.CrossRefPubMed
Metadata
Title
Microbiologic diagnostics and pathogen spectrum in infective endocarditis of surgically treated patients: a five-year, retrospective, monocentric study
Authors
Renate Ziegler
Hendrik Arnold
Ralph Bertram
Walter Geißdörfer
Matthias Pauschinger
Theodor Fischlein
Francesco Pollari
Joerg Steinmann
Publication date
07-04-2023
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2023
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-023-02030-x

Other articles of this Issue 5/2023

Infection 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine